| Product | Indications | Preclinical | Phase 1 | Phase 2 | Phase 3 | Status |
|---|---|---|---|---|---|---|
Validive® |
Chemoradiation induced SOM |
Preclinical complete |
Phase 1 complete |
Phase 2 in progress |
Phase 3 not started |
Phase 2b/3 VOICE trial ongoing |
Camsirubicin |
Advanced Soft Tissue Sarcoma |
Preclinical complete |
Phase 1 in progress |
Phase 2 not started |
Phase 3 not started |
Phase 1b planned H2 2021 |
MNPR-101 RIT |
Advanced Solid Cancers, Severe COVID-19 |
Preclinical in progress |
Phase 1 not started |
Phase 2 not started |
Phase 3 not started |
Collaboration with NorthStar |
MNPR-101 |
Solid Cancers |
Preclinical in progress |
Phase 1 not started |
Phase 2 not started |
Phase 3 not started |
Late preclinical |
MNPR-202 |
Advanced Solid Cancers |
Preclinical in progress |
Phase 1 not started |
Phase 2 not started |
Phase 3 not started |
Early preclinical |
